Farasat A.S. Bokhari
Names
| first: |
Farasat |
| middle: |
A.S. |
| last: |
Bokhari |
Identifer
Contact
Affiliations
-
University of East Anglia
/ Centre for Competition Policy (weight: 50%)
-
University of East Anglia
/ School of Economics (weight: 50%)
Research profile
author of:
- Lockdown drinking: The sobering effect of price controls in a pandemic (RePEc:bla:ecinqu:v:62:y:2024:i:4:p:1539-1557)
by Farasat A. S. Bokhari & Ratula Chakraborty & Paul W. Dobson & Marcello Morciano - Entry limiting agreements: First‐mover advantage, authorized generics, and pay‐for‐delay deals (RePEc:bla:jemstr:v:29:y:2020:i:3:p:516-542)
by Farasat A. S. Bokhari & Franco Mariuzzo & Arnold Polanski - Open Versus Closed Firms And The Dynamics Of Industry Evolution (RePEc:bla:jindec:v:55:y:2007:i:3:p:499-527)
by Ashish Arora & Farasat A. S. Bokhari - Entry in the ADHD drugs market: Welfare impact of generics and me-too's (RePEc:bla:jindec:v:61:y:2013:i:2:p:339-392)
by Farasat A. S. Bokhari & Gary M. Fournier - Assessing the impact of health care expenditures on mortality using cross-country data (RePEc:chy:respap:128cherp)
by Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno Serra & Marc Suhrcke - Banning volume discounts to curb excessive consumption: A cautionary tale (RePEc:eee:eecrev:v:156:y:2023:i:c:s0014292123001095)
by Bokhari, Farasat A.S. & Dobson, Paul W. & Morciano, Marcello & Suhrcke, Marc - Managed care competition and the adoption of hospital technology: The case of cardiac catheterization (RePEc:eee:indorg:v:27:y:2009:i:2:p:223-237)
by Bokhari, Farasat A.S. - Demand estimation and merger simulations for drugs: Logits v. AIDS (RePEc:eee:indorg:v:61:y:2018:i:c:p:653-685)
by Bokhari, Farasat A.S. & Mariuzzo, Franco - Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics (RePEc:eee:indorg:v:95:y:2024:i:c:s0167718724000377)
by Bokhari, Farasat A.S. & Mariuzzo, Franco & Yan, Weijie - School accountability laws and the consumption of psychostimulants (RePEc:eee:jhecon:v:30:y:2011:i:2:p:355-372)
by Bokhari, Farasat A.S. & Schneider, Helen - Discrimination in healthcare: A field experiment with Pakistan's transgender community (RePEc:eee:labeco:v:87:y:2024:i:c:s0927537123001653)
by Ahmad, Husnain F & Banuri, Sheheryar & Bokhari, Farasat - Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market (RePEc:esr:wpaper:wp678)
by Bokhari, Farasat A. S. & Yan, Weijie - Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catherterization (RePEc:fsu:wpaper:wp2001_10_02)
by Farasat A.S. Bokhari - An analysis of the significant variation in psychostimulant use across the U.S (RePEc:fsu:wpaper:wp2003_01_01)
by Farasat A.S. Bokhari & Rick Mayes & Richard M. Scheffler - Government Health Expenditures and Health Outcomes (RePEc:fsu:wpaper:wp2005_02_01)
by Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret - School accountability laws and the consumption of psychostimulants (RePEc:fsu:wpaper:wp2009_03_02)
by Farasat A.S. Bokhari & Helen Schnedier - Entry in the ADHD drugs market: Welfare impact of generics and me-toos (RePEc:fsu:wpaper:wp2009_05_01)
by Farasat A.S. Bokhari & Gary M. Fournier - Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions (RePEc:kap:sbusec:v:57:y:2021:i:1:d:10.1007_s11187-019-00307-w)
by Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato - What Is The Price Of Pay-To-Delay Deals? (RePEc:oup:jcomle:v:9:y:2013:i:3:p:739-753.)
by Farasat A.S. Bokhari - Selective admission into stroke unit and patient outcomes: a tale of four cities (RePEc:spr:hecrev:v:4:y:2014:i:1:p:1-10:10.1186/2191-1991-4-1)
by Farasat Bokhari & Ian Wellwood & Anthony Rudd & Peter Langhorne & Martin Dennis & Charles Wolfe - What is the price of pay-to-delay deals? (RePEc:uea:ueaccp:2013_01)
by Farasat A.S. Bokhari - Entry limiting agreements: First mover advantage, authorized generics and pay-for-delay deals (RePEc:uea:ueaccp:2015_05v4)
by Farasat A.S. Bokhari & Franco Mariuzzo & Arnold Polanski - Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions (RePEc:uea:ueaccp:2016_01v3)
by Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato - Demand estimation and merger simulations for drugs: Logits v. AIDS (RePEc:uea:ueaccp:2016_06v3)
by Farasat A.S. Bokhari & Franco Mariuzzo - Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics (RePEc:uea:ueaccp:2019_03)
by Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan - Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market (RePEc:uea:ueaccp:2020_04)
by Farasat A.S. Bokhari & Weijie Yan - Banning Volume Discounts to Curb Excessive Consumption: A Cautionary Tale (RePEc:uea:ueaccp:2022_04)
by Farasat A.S. Bokhari & Paul W. Dobson - Government health expenditures and health outcomes (RePEc:wly:hlthec:v:16:y:2007:i:3:p:257-273)
by Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret - Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catheterization (RePEc:wpa:wuwphe:0110001)
by Farasat A.S. Bokhari - Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution (RePEc:wpa:wuwpio:9606002)
by Ashish Arora & Farasat Bokhari - Optimum Population -- A New Look: A Hamiltonian Approach Towards A Dynamic Analysis (RePEc:wpa:wuwpla:9607002)
by Farasat Bokhari & George W. McCarthy - Assessing the Impact of Health Care Expenditures on Mortality Using Cross-Country Data (RePEc:wsi:wschap:9789813272378_0001)
by Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno-Serra & Marc Suhrcke & Peter Berman - A Comment on Sampson (2023) (RePEc:zbw:i4rdps:114)
by Angenendt, David & Bokhari, Farasat & Mariusso, Franco & Zhang, Junjun